Hospital Clinico Universitario Virgen de la Arrixaca

Murcia 30120 El Palmar,

3 studies enrolling now · 9 studies all time

What they study most

Aortic Stenosis, Aortic Valve Disease, Breast Neoplasms, Chronic Lymphocytic Leukemia, Epithelial Ovarian Cancer, Fallopian Tube Cancer, Marginal Zone Lymphoma, Obstructive Hypertrophic Cardiomyopathy (oHCM), Peritoneal Cancer, Platinum-resistant Ovarian Cancer, Primary Peritoneal Cancer, Relapsed/Refractory Follicular Lymphoma

Studies at this site

• A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia — Recruiting now
• A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy — Recruiting now
• REtroperitoneal SArcoma Registry: an International Prospective Initiative — Recruiting now
• A Study of Zanubrutinib Plus Anti-CD20 Versus Lenalidomide Plus Rituximab in Participants With Relapsed/Refractory Follicular or Marginal Zone Lymphoma — Running, not enrolling
• Phase 3 Trial to Evaluate the Efficacy and Safety of Aficamten Compared to Placebo in Adults With Symptomatic oHCM — Completed
• Phase 3 Study of Nemvaleukin Alfa in Combination With Pembrolizumab in Patients With Platinum-Resistant Epithelial Ovarian Cancer (ARTISTRY-7) — Stopped early
• A Study of Mirvetuximab Soravtansine in Platinum-Resistant, Advanced High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancers With High Folate Receptor-Alpha Expression — Completed
• Perceval Sutureless Implant Versus Standard-Aortic Valve Replacement — Stopped early
• Sapanisertib in Combination With Fulvestrant in Women With Advanced or Metastatic Breast Cancer After Aromatase Inhibitor Therapy — Completed